Form 4 for GILD Gilead Sciences
Accepted 2026-02-06 00:00:00 ET · period of report 2026-02-05 · accession 0001638643-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-06 | 2026-02-05 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | $66.01 | +115.6K | 729.6K | +19% | +$7.63M |
| D | 2026-02-06 | 2026-02-05 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale+OE | $150.00 | -115.6K | 613.9K | -16% | -$17.35M |
| D | 2026-02-06 | 2026-02-05 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | $0.00 | -115.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-05 | M | A | 115,640 | $66.01 | 729,552 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-05 | S | D | 115,640 | $150.00 | 613,912 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-02-05 | M | D | 115,640 | $0.00 | 0 | D | $66.01 · — to 2029-03-01 | 115,640 Common Stock | (F2) The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |